Skip to main content
Erschienen in: International Urology and Nephrology 3/2017

02.01.2017 | Urology - Original Paper

Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser

verfasst von: Luca Cindolo, Lorenzo Ruggera, Paolo Destefanis, Claudio Dadone, Giovanni Ferrari

Erschienen in: International Urology and Nephrology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purposes

GreenLight laser has gained increasing acceptance as a less invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH/LUTS). Three surgical options were developed: standard photovaporization (PVP), anatomical PVP and GreenLight enucleation of prostate (GreenLEP); however, literature lacks a direct comparison among the procedures. Aim of the present study is to compare the three techniques in a multicentre series of patients.

Methods

Data were collected from consecutive patients with indication to surgical management of BPH/LUTS in five institutions. Patients underwent standard PVP, anatomical PVP or GreenLEP according to surgeon preferences. Standard parameters associated with transurethral prostate surgery were documented prior surgery and during the follow-up. Patients’ perception of improvement was measured using a single-item scale. Early (within first 30 post-operative days) and delayed post-operative complications were recorded. Descriptive statistics, univariate and multivariate analysis were used.

Results

We evaluate 367 consecutive patients (mean age 69.1 years). Median prostate size and PSA were 68 ml (IQR 50–90) and 2.8 ng/ml (IQR 1.7–4.3), respectively. The median operative time and applied energy were 60 min (IQR 45–75) and 250 kJ (IQR 160–364). Catheterization time and median post-operative stay were 1 and 2 days. No patient was transfused. The overall median Q max values increased for 8–19 ml/s (p < 0.05), median International Prostate Symptoms Score decreased from 24 to 7 (p < 0.05). A total of 7.4% urinary retention, 33.4% bothersome storage symptoms, 2.5% short-term stress incontinence were recorded. Three heart attacks, one pulmonary embolism and one death occurred. Prostate volume was a predictive factor for post-operative storage symptoms (p = 0.049). Nine percentage of patients experienced long-term complications (4, 0.9 and 0.9% of urethral stricture, bladder neck contracture and prostatic fossa sclerosis, respectively) with 2.5% of long-term stress urinary incontinence (conservatively managed). The reintervention rate was 6%. Late complications were associated at univariate analysis with pharmacological therapy (combination therapy vs. alpha blockers alone vs. none: p value = 0.042) and with the surgical approach (standard PVP vs. anatomical PVP vs. GreenLEP p value = 0.011). The patients’ perception of satisfaction was 68% “greatly improved”, 27% “improved”, 4% “not changed” and 1% “worsened” with no differences between techniques.

Conclusion

The availability of three different GreenLight laser techniques allows surgeons with different skills to safety use this technology that remains effective with high patient satisfaction. Anatomical vaporization seems to guarantee the best balance between functional outcomes, surgical procedures and complications.
Literatur
1.
Zurück zum Zitat Sato K, Obinata D, Funakoshi D et al (2016) Efficacies of transurethral prostate enucleation by bipolar system for patients with benign prostatic hyperplasia. Minerva Urol E Nefrol Ital J Urol Nephrol 68(4):337–341 Sato K, Obinata D, Funakoshi D et al (2016) Efficacies of transurethral prostate enucleation by bipolar system for patients with benign prostatic hyperplasia. Minerva Urol E Nefrol Ital J Urol Nephrol 68(4):337–341
2.
Zurück zum Zitat Cindolo L, Pirozzi L, Fanizza C et al (2015) Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol 68:418–425. doi:10.1016/j.eururo.2014.11.006 CrossRefPubMed Cindolo L, Pirozzi L, Fanizza C et al (2015) Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol 68:418–425. doi:10.​1016/​j.​eururo.​2014.​11.​006 CrossRefPubMed
3.
Zurück zum Zitat Cindolo L, Pirozzi L, Sountoulides P et al (2015) Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy? BMC Urol 15:96. doi:10.1186/s12894-015-0090-x CrossRefPubMedPubMedCentral Cindolo L, Pirozzi L, Sountoulides P et al (2015) Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy? BMC Urol 15:96. doi:10.​1186/​s12894-015-0090-x CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Berardinelli F, Hinh P, Wang R (2009) Minimally invasive surgery in the management of benign prostatic hyperplasia. Minerva Urol E Nefrol Ital J Urol Nephrol 61:269–289 Berardinelli F, Hinh P, Wang R (2009) Minimally invasive surgery in the management of benign prostatic hyperplasia. Minerva Urol E Nefrol Ital J Urol Nephrol 61:269–289
7.
Zurück zum Zitat Castellan P, Castellucci R, Schips L, Cindolo L (2015) Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature. World J Urol 33:599–607. doi:10.1007/s00345-015-1490-y CrossRefPubMed Castellan P, Castellucci R, Schips L, Cindolo L (2015) Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature. World J Urol 33:599–607. doi:10.​1007/​s00345-015-1490-y CrossRefPubMed
9.
Zurück zum Zitat Gomez Sancha F, Rivera VC, Georgiev G et al (2015) Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol 33:539–547. doi:10.1007/s00345-014-1339-9 CrossRefPubMed Gomez Sancha F, Rivera VC, Georgiev G et al (2015) Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol 33:539–547. doi:10.​1007/​s00345-014-1339-9 CrossRefPubMed
10.
Zurück zum Zitat Misrai V, Kerever S, Phe V et al (2016) Direct comparison of GreenLight laser XPS photoselective prostate vaporization and GreenLight laser en bloc enucleation of the prostate in enlarged glands greater than 80 ml: a study of 120 patients. J Urol 195:1027–1032. doi:10.1016/j.juro.2015.10.080 CrossRefPubMed Misrai V, Kerever S, Phe V et al (2016) Direct comparison of GreenLight laser XPS photoselective prostate vaporization and GreenLight laser en bloc enucleation of the prostate in enlarged glands greater than 80 ml: a study of 120 patients. J Urol 195:1027–1032. doi:10.​1016/​j.​juro.​2015.​10.​080 CrossRefPubMed
11.
Zurück zum Zitat Peterson B, Harrell FE (1990) Partial proportional odds models for ordinal response variables. J R Stat Soc Ser C Appl Stat 39:205–217. doi:10.2307/2347760 Peterson B, Harrell FE (1990) Partial proportional odds models for ordinal response variables. J R Stat Soc Ser C Appl Stat 39:205–217. doi:10.​2307/​2347760
13.
Zurück zum Zitat Elshal AM, Elkoushy MA, El-Nahas AR et al (2015) GreenLightTM laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 193:927–934. doi:10.1016/j.juro.2014.09.097 CrossRefPubMed Elshal AM, Elkoushy MA, El-Nahas AR et al (2015) GreenLightTM laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol 193:927–934. doi:10.​1016/​j.​juro.​2014.​09.​097 CrossRefPubMed
16.
17.
19.
Zurück zum Zitat Robert G, Cornu J-N, Fourmarier M et al (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117:495–499. doi:10.1111/bju.13124 CrossRefPubMed Robert G, Cornu J-N, Fourmarier M et al (2016) Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int 117:495–499. doi:10.​1111/​bju.​13124 CrossRefPubMed
Metadaten
Titel
Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser
verfasst von
Luca Cindolo
Lorenzo Ruggera
Paolo Destefanis
Claudio Dadone
Giovanni Ferrari
Publikationsdatum
02.01.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 3/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1494-6

Weitere Artikel der Ausgabe 3/2017

International Urology and Nephrology 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.